Comparison

Ragaglitazar European Partner

Item no. TMO-T28501-500mg
Manufacturer TargetMol
CASRN 222834-30-2
Amount 500 mg
Quantity options 100 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C25H25NO5
Smiles C(COC1=CC=C(C[C@H](OCC)C(O)=O)C=C1)N2C=3C(OC=4C2=CC=CC4)=CC=CC3
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias NNC61-0029,NN-622,(-)-DRF-2725,NNC-61-0029,NN 622,NNC 61-0029
Shipping Condition Cool pack
Available
Manufacturer - Targets
PPAR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
419.47
Description
Ragaglitazar(NNC-61-0029) is a potent dual activator of PPARγ and PPARα, which shows improved insulin sensitization and lipid-lowering potential in animal models and can be used to study type 2 diabetes.
Pathways
Metabolism|||DNA Damage/DNA Repair
Bioactivity
Ragaglitazar, a PPARalpha and PPARgamma Agonist, is used potentially for diabetics.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close